Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.
Ting-Tse LinCho-Kai WuMin-Tsun LiaoYao-Hsu YangPau-Chung ChenDong-Feng YeihLian-Yu LinPublished in: PloS one (2017)
Therapy of ACEIs or ARBs is associated with a lower risk of MI among patients with RA. Hence, hypertension in patients with RA could comprise a compelling indication for RAS inhibitors.